Healthcare for Older People

Permanent URI for this collection

Research outputs from the Healthcare for Older People department at the RD&E.


Recent Submissions

Now showing 1 - 5 of 114
  • Item
    Builder, Expert, Disruptor, Leader: The Many Roles of People with Lived Experience
    (Ubiquity Press, 2023-08-23) Miller, R.; Ehrenberg, N.; Jackson, C.; Penwarden, H.; Stein, V.; van der Vlegel-Brouwer, W.; Wojtak, A.
    People with lived experience of health and social care, including family carers, should be at the heart of integrated care policy and practice. One of the challenges to achieving such co-production is insufficient clarity and limited understanding of the different roles that people with lived experience are asked or choose to undertake. Following research and workshops, four roles have been identified - community builder, improvement expert, disruptor/advocate, and citizen leader. Recognising the distinct contribution and demands of these roles will enable appropriate support and development for people with lived experience and the professionals and managers with whom they collaborate.
  • Item
    PROTOCOL: Health and social care interventions in the 80 years old and over population: An evidence and gap map
    (Wiley Open Access, 2023-06-01) Abbott, R.; Thompson Coon, J.; Bethel, A.; Rogers, M.; Whear, R.; Orr, N.; Garside, R.; Goodwin, V.; Mahmoud, A.; Lourida, I.; Cheeseman, D.
    This is the protocol for a Campbell systematic review. The objectives are as follows: identify available systematic reviews and randomised controlled trials on interventions targeting health or social needs of the people aged over 80; identify qualitative studies relating to the experiences of people aged over 80 of interventions that target their health or social needs; identify areas where systematic reviews are needed; identify gaps in evidence where further primary research is needed; assess equity considerations (using the PROGRESS plus criteria) in available systematic reviews, randomised trials and qualitative studies of identified interventions; assess gaps and evidence related to health equity.
  • Item
    Atrial fibrillation, transient ischaemic attack and stroke in older people. A themed collection in age and ageing journal
    (Oxford University Press, 2023-05-01) Mensah, E. A.; Masoli, J. A. H.; Rajkumar, C.
    With an increase in the ageing population, there is a rise in the burden of cardiovascular disease. Age and Ageing have compiled collections of their key cardiovascular themed papers. The first Age and Ageing Cardiovascular Collection focussed on blood pressure, coronary heart disease and heart failure. In this second collection, publications since 2011 were selected with emphasis on atrial fibrillation, transient ischaemic attack (TIA) and stroke. The prevalence of TIA and stroke increases as people get older. In this commentary we summarise studies published in Age and Ageing that bring to the fore the need for a multidisciplinary, person-centred approach to care, conscientious identification of risk factors and their management and prevention strategies, which will inform policy ultimately reducing the burden of cost placed by stroke care on healthcare financing. Read the latest Cardiovascular Collection here.
  • Item
    New horizons in the role of digital data in the healthcare of older people
    (Oxford University Press, 2023-08-01) Masoli, J. A. H.; Todd, O.; Burton, J. K.; Wolff, C.; Walesby, K. E.; Hewitt, J.; Conroy, S.; van Oppen, J.; Wilkinson, C.; Evans, R.; Anand, A.; Hollinghurst, J.; Bhanu, C.; Keevil, V. L.; Vardy, Erlc
    There are national and global moves to improve effective digital data design and application in healthcare. This New Horizons commentary describes the role of digital data in healthcare of the ageing population. We outline how health and social care professionals can engage in the proactive design of digital systems that appropriately serve people as they age, carers and the workforce that supports them. KEY POINTS: Healthcare improvements have resulted in increased population longevity and hence multimorbidity. Shared care records to improve communication and information continuity across care settings hold potential for older people. Data structure and coding are key considerations. A workforce with expertise in caring for older people with relevant knowledge and skills in digital healthcare is important.
  • Item
    STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: A structured protocol
    (PLoS One, 2023-02-15) Forshaw, D.; Wall, E. C.; Prescott, G.; Dehbi, H. M.; Green, A.; Attree, E.; Hismeh, L.; Strain, W. D.; Crooks, M. G.; Watkins, C.; Robson, C.; Banerjee, R.; Lorgelly, P.; Heightman, M.; Banerjee, A.
    INTRODUCTION: Long COVID (LC), the persistent symptoms ≥12 weeks following acute COVID-19, presents major threats to individual and public health across countries, affecting over 1.5 million people in the UK alone. Evidence-based interventions are urgently required and an integrated care pathway approach in pragmatic trials, which include investigations, treatments and rehabilitation for LC, could provide scalable and generalisable solutions at pace. METHODS AND ANALYSIS: This is a pragmatic, multi-centre, cluster-randomised clinical trial of two components of an integrated care pathway (Coverscan™, a multi-organ MRI, and Living with COVID Recovery™, a digitally enabled rehabilitation platform) with a nested, Phase III, open label, platform randomised drug trial in individuals with LC. Cluster randomisation is at level of primary care networks so that integrated care pathway interventions are delivered as standard of care" in that area. The drug trial randomisation is at individual level and initial arms are rivaroxaban, colchicine, famotidine/loratadine, compared with no drugs, with potential to add in further drug arms. The trial is being carried out in 6-10 LC clinics in the UK and is evaluating the effectiveness of a pathway of care for adults with LC in reducing fatigue and other physical, psychological and functional outcomes at 3 months. The trial also includes an economic evaluation which will be described separately. ETHICS AND DISSEMINATION: The protocol was reviewed by South Central-Berkshire Research Ethics Committee (reference: 21/SC/0416). All participating sites obtained local approvals prior to recruitment. Coverscan™ has UK certification (UKCA 752965). All participants will provide written consent to take part in the trial. The first participant was recruited in July 2022 and interim/final results will be disseminated in 2023, in a plan co-developed with public and patient representatives. The results will be presented at national and international conferences, published in peer reviewed medical journals, and shared via media (mainstream and social) and patient support organisations. TRIAL REGISTRATION NUMBER: ISRCTN10665760."